Status:

SUSPENDED

Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS

Lead Sponsor:

Negovsky Reanimatology Research Institute

Conditions:

Acute Respiratory Distress Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The American European Consensus Conference (AECC) 1994 defined acute respiratory distress syndrome (ARDS) as an acute inflammatory syndrome manifesting as diffuse pulmonary edema and respiratory failu...

Eligibility Criteria

Inclusion

  • Age \> 18
  • Endotracheal intubation or tracheostomy
  • Timing: Acute onset of new or worsening of chronic respiratory symptoms within 72 hours before the randomization
  • Chest imaging: Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules
  • Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload
  • Oxygenation: 100 mm Hg \< PaO2/FiO2 ≤ 200 mm Hg with PEEP ≥ 5 cm H2O

Exclusion

  • History or family history of malignant hyperthermia
  • History of propofol infusion syndrome
  • Documented or suspected increased intracranial pressure
  • Chronic restrictive pulmonary disease
  • Chronic obstructive pulmonary disease
  • Neuromuscular disease
  • Chest wall disorder
  • Pulmonary vascular disease
  • NYHA class ≥ 3
  • Severe pulmonary hypertension (mean pulmonary artery pressure \> 40 mmHg)
  • Documented ongoing COVID-19 infection
  • Ongoing immunosuppressive therapy
  • Previous randomization in this trial
  • Post randomization exclusion criterion: Documented ongoing COVID-19 infection during the first 48 hours after the randomization

Key Trial Info

Start Date :

March 14 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 25 2026

Estimated Enrollment :

310 Patients enrolled

Trial Details

Trial ID

NCT05259631

Start Date

March 14 2022

End Date

February 25 2026

Last Update

February 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Demikhov Municipal Clinical Hospital 68

Moscow, Russia